Programme
9:45 - 10:10
Registration & welcome coffee
10:15 - 10:45
Dr. Xavier Gidrol (Keynote 1)
Biosciences and Biotechnologies Institute in Grenoble, France
Organs & organoids-on-chip in development and oncology
10:50 - 11:20
Jun. Prof. Dr. Peter Loskill (Keynote 2)
Fraunhofer IGB, Stuttgart
Integrated organ-on-an-chip systems: Advanced microphysological plattforms recapitulating complex human tissue
11:30 - 11:45
Dr. Daniel Riveline
Institute of Genetics and Molecular and Cellular Biology (IGBMC), Illkirch-Graffenstaden, France
Self-organisation in living matter: from cytokinesis and cell motility to the morphogensis of organoids
11:50 - 12:30
Short Presentation Session
12:30 - 13:40
Networking lunch
13:40 - 13:50
Biovalley France & BIOPRO Baden-Württemberg GmbH
14:00 - 14:15
Prof. Dr. Ute Schepers
vasQlab, Eggenstein-Leopoldshafen
Topic: Body-on-a-chip systems
14:15 - 14:30
Dr. Nihal Engin Vrana
SPARTHA MEDICAL, Strasbourg, France
PANBioRA: An Integrated Personalised Biomaterial Risk Assessment Instrument with organ-on-a-chip modules
14:30 - 14:45
Dr. Paolo Cesare
NMI – Natural and Medical Sciences Institute, Reutlingen
Development of a 3D in vitro phenotypic platform for interrogating 3D neuronal networks
14:45 - 15:00
Dr. Thibault Honegger
Neuro Engineering Technologies Research Institute (NETRI), Lyon, France
Organ-on-chip approaches for neurosciences
15:00 - 16:00
Networking coffee break
16:00 - 16:15
Dr. Brigitte Angres
Cellendes GmbH, Reutlingen
3-D Life Biometic Hydrogel Technology and its application for organoid and other 3D cell cultures
16:15 - 16:30
Dr. Eric Leclerc
French National Centre for Scientific Research, Paris, France
Development of liver on chip technology applied to liver hepatic regeneration and predictive toxicology
16:30 -16:45
Dr. Peter Koltay
IMTEK – Department of Microsystems Engineering University of Freiburg
Recent developments in the 3D-Bio-Net project regarding in vitro models for vascularization studies
16:45 - 17:00
Dr. Sylvia Wagner
Fraunhofer IBMT, Sulzbach (Saar)
Advanced in vitro models for preclinical testing of new drug formulations
17:30
End of the event